File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1007/s10792-013-9893-5
- Scopus: eid_2-s2.0-84904334008
- WOS: WOS:000341838400022
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Surgical outcome of involutional lower eyelid entropion correction using transcutaneous everting sutures in Chinese patients
Title | Surgical outcome of involutional lower eyelid entropion correction using transcutaneous everting sutures in Chinese patients |
---|---|
Authors | |
Keywords | Aged Aged, 80 and over Asian Continental Ancestry Group China Entropion/*surgery Female Follow-Up Studies Humans Male Recurrence Retrospective Studies *Suture Techniques |
Issue Date | 2014 |
Citation | International Ophthalmology, 2014, v. 34 n. 4, p. 865-868 How to Cite? |
Abstract | To evaluate the clinical efficacy of transcutaneous everting sutures for lower eyelid involutional entropion in Chinese patients. A retrospective, non-comparative, interventional case series. This retrospective study consecutively reviewed the medical records of all patients with involutional lower eyelid entropion who underwent transcutaneous everting suture for entropion correction at the Department of Ophthalmology, Caritas Medical Centre, from 1st January 2010 to 31st October 2013. Exclusion criteria included concurrent eyelid pathologies such as malignant tumor, infection, cicatricial entropion, post-operative follow-up period of <3 months, significant horizontal lid laxity, and aged <60 years at the time of surgery. The primary outcome measures were recurrence rate and complications. Secondary outcome measures included patient demographic data, type and number of everting sutures, duration of operation, timing of stitch removal, duration of follow-up, as well as each patient's medical history and current medications. Thirty-four eyelids of 28 patients were included. The average age was 78.2 +/- 7.3 years and the male to female ratio was 4:3. In this series, 26.5 and 2.9 % of eyelids underwent entropion correction whilst receiving aspirin and warfarin, respectively. The mean duration of post-operative follow-up was 13.2 +/- 10.5 months. The recurrence rate was 11.8 % at a mean of 9.0 +/- 6.0 months. There were no peri-operative or post-operative complications observed. A transcutaneous everting suture was found to be a quick and effective means to correct senile involutional lower lid entropion in Chinese patients with no complications despite the continued use of anti-coagulation therapy in >25 % of our cases. |
Persistent Identifier | http://hdl.handle.net/10722/208479 |
ISSN | 2023 Impact Factor: 1.4 2023 SCImago Journal Rankings: 0.709 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Tsang, S | en_US |
dc.contributor.author | Yau, GS | en_US |
dc.contributor.author | Lee, WYJ | en_US |
dc.contributor.author | Chu, AT | en_US |
dc.contributor.author | Yuen, CY | en_US |
dc.date.accessioned | 2015-03-11T07:06:17Z | - |
dc.date.available | 2015-03-11T07:06:17Z | - |
dc.date.issued | 2014 | en_US |
dc.identifier.citation | International Ophthalmology, 2014, v. 34 n. 4, p. 865-868 | en_US |
dc.identifier.issn | 1573-2630 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/208479 | - |
dc.description.abstract | To evaluate the clinical efficacy of transcutaneous everting sutures for lower eyelid involutional entropion in Chinese patients. A retrospective, non-comparative, interventional case series. This retrospective study consecutively reviewed the medical records of all patients with involutional lower eyelid entropion who underwent transcutaneous everting suture for entropion correction at the Department of Ophthalmology, Caritas Medical Centre, from 1st January 2010 to 31st October 2013. Exclusion criteria included concurrent eyelid pathologies such as malignant tumor, infection, cicatricial entropion, post-operative follow-up period of <3 months, significant horizontal lid laxity, and aged <60 years at the time of surgery. The primary outcome measures were recurrence rate and complications. Secondary outcome measures included patient demographic data, type and number of everting sutures, duration of operation, timing of stitch removal, duration of follow-up, as well as each patient's medical history and current medications. Thirty-four eyelids of 28 patients were included. The average age was 78.2 +/- 7.3 years and the male to female ratio was 4:3. In this series, 26.5 and 2.9 % of eyelids underwent entropion correction whilst receiving aspirin and warfarin, respectively. The mean duration of post-operative follow-up was 13.2 +/- 10.5 months. The recurrence rate was 11.8 % at a mean of 9.0 +/- 6.0 months. There were no peri-operative or post-operative complications observed. A transcutaneous everting suture was found to be a quick and effective means to correct senile involutional lower lid entropion in Chinese patients with no complications despite the continued use of anti-coagulation therapy in >25 % of our cases. | en_US |
dc.language | eng | en_US |
dc.relation.ispartof | International Ophthalmology | en_US |
dc.subject | Aged | en_US |
dc.subject | Aged, 80 and over | en_US |
dc.subject | Asian Continental Ancestry Group | en_US |
dc.subject | China | en_US |
dc.subject | Entropion/*surgery | en_US |
dc.subject | Female | en_US |
dc.subject | Follow-Up Studies | en_US |
dc.subject | Humans | en_US |
dc.subject | Male | en_US |
dc.subject | Recurrence | en_US |
dc.subject | Retrospective Studies | en_US |
dc.subject | *Suture Techniques | en_US |
dc.title | Surgical outcome of involutional lower eyelid entropion correction using transcutaneous everting sutures in Chinese patients | en_US |
dc.type | Article | en_US |
dc.identifier.email | Lee, WYJ: jackylee@hku.hk | en_US |
dc.identifier.authority | Lee, WYJ=rp01498 | en_US |
dc.identifier.doi | 10.1007/s10792-013-9893-5 | en_US |
dc.identifier.scopus | eid_2-s2.0-84904334008 | - |
dc.identifier.volume | 34 | en_US |
dc.identifier.issue | 4 | en_US |
dc.identifier.spage | 865 | en_US |
dc.identifier.epage | 868 | en_US |
dc.identifier.isi | WOS:000341838400022 | - |
dc.identifier.issnl | 0165-5701 | - |